CN(C)c1ccc(/C=C(/NC(=O)c2ccccc2)c2nc3cc(Cl)ccc3[nH]2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?